Meri, Seppo
Seppo Meri Finnish physician, MD, PhD, professor of immunology (University of Helsinki)
VIAF ID: 305669981 ( Personal )
Permalink: http://viaf.org/viaf/305669981
Preferred Forms
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Eculizumab - a first-in-class terminal pathway complement inhibitor, [2012?]: | |
ORPHEUS 2007 : Europan PhD Programs in Clinical Medicine : proceedings of the Third Conference on Biomedical and Health Science Doctoral Training in Europe, Helsinki, September 6-8, 2007 |